Drug-eluting stents (DES)

Today’s PCI standard — compare drug, polymer and strut thickness.

10 results

Everolimus stent with a fluoropolymer and one of the largest clinical evidence bases.

Drug: Everolimus

Everolimus stent with abluminal bioabsorbable polymer; MEGATRON for large vessels and left main.

Drug: Everolimus

Zotarolimus stent with Pt-Ir core for visibility; 2.0 mm size for small vessels.

Drug: Zotarolimus

Ultrathin (60 µm) sirolimus stent with biodegradable polymer.

Drug: Sirolimus

Sirolimus stent with abluminal gradient bioresorbable coating.

Drug: Sirolimus

Low-dose sirolimus stent with drug in recessed abluminal grooves.

Drug: Sirolimus (low dose, recessed abluminal grooves)

Thin-strut sirolimus stent with hybrid cell design.

Drug: Sirolimus

Ultrathin-strut sirolimus stent.

Drug: Sirolimus

Polymer-free stent studied in high-bleeding-risk patients with short dual antiplatelet therapy.

Drug: Biolimus A9

Italian polymer-free stent with abluminal drug reservoirs; studied in diabetic patients.

Drug: Amphilimus (sirolimus + fatty acid)